{
  "docId": "019de517-75a1-7387-968b-d0dc513bf421",
  "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
  "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
  "authorId": "ocuphire-pharma",
  "authorName": "Ocuphire Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 40,
  "pageCount": 42,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/40",
  "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
  "deckJsonHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421.json",
  "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.69,
        "w": 0.68,
        "x": 0.29,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "Other Cholinergic Agonists*\nAlpha Antagonist\nOcuphire Phentolamine Ophthalmic Solution 0.75%\nOcuphire Phentolamine Ophthalmic Solution 0.75% + 0.4% pilo\nLens Softening\nLenz Aceclidine; Aceclidine + brim\nVisus Brimochol® (carbachol + brim)\nEyenovia MicroLine (2% pilo)\nAllergan VUITY™: (1.25% pilo)\nOrasis CSF-1 (Low dose pilo)\nNovartis EV-006\nNDA\nPhase 3\nPhase 2\nPhase 1\nCholinergic Agonist* (pilocarpine)",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0a283b6-e6fc-4cdc-864e-a169ec74a08a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.24,
        "x": 0.05,
        "y": 0.21
      },
      "kind": "list",
      "text": "POS's potential differentiation:\n1) New MOA class (iris dilator muscle inhibitor)\n2) Favorable safety and tolerability (e.g.: no headaches, no accommodative spasm, no risk of retinal detachment)\n3) 24-hour durability\n4) Broad range of patients including high myopes\n5) Improvement in night vision disturbances",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "151717cd-2c5f-4153-94f5-8b8e34676aa3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.1,
        "x": 0.87,
        "y": 0.18
      },
      "kind": "list",
      "text": "Pupil modulation MOA\nCombination drugs\nLens softening MOA",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36e99062-e0aa-4e18-bb1f-be8336d6998a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.24,
        "x": 0.05,
        "y": 0.76
      },
      "kind": "list",
      "text": "POS+LDP may offer added efficacy and tunability",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9475fbf-2180-4b90-9e4e-c55bd509b3cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.02,
        "x": 0.95,
        "y": 0.95
      },
      "kind": "other",
      "text": "40",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dea32404-319f-4fce-83a9-3c2a72a0a775",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.1,
        "x": 0.87,
        "y": 0.42
      },
      "kind": "source-note",
      "text": "* acts on sphincter and ciliary muscles in dose-dependent manner",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5305a2c9-f03a-4f7f-a14b-ff4a7ab81dc0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.46,
        "x": 0.11,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Corporate Websites as of October 31, 2023,\nGrzybowski, A, Markeviciute A, Zemaitiene R. A Review of Pharmacological Presbyopia Treatment. 2020",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3b63d18-a19b-40fc-bd28-b1de194a614b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.89,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "A New, Differentiated MOA and Combination Therapy Offers Tunability",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef011426-416c-4b61-b8ff-6ffee0a14751",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "46d1333e-ffc6-41e6-88c0-3e006f4b5399",
      "evidence": "diagram/unclassified: Other Cholinergic Agonists* Alpha Antagonist Ocuphire Phentolamine Ophthalmic Solution 0.75%",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 42,
      "from": 29,
      "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}